WallStreetZenWallStreetZen

NASDAQ: BCLI
Brainstorm Cell Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BCLI stock forecasts and price targets.

Forecast return on equity

Is BCLI forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is BCLI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BCLI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCLI$0.60N/AN/A
SRZN$14.33N/AN/A
TCRT$1.86N/AN/A
SPRB$0.74$5.40+629.73%Buy
CDIO$1.37N/AN/A

Brainstorm Cell Therapeutics Stock Forecast FAQ

What is BCLI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BCLI) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Brainstorm Cell Therapeutics stock.

What is BCLI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BCLI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.